Chikungunya – Safe in Pregnancy

Resources

Chikungunya

SADI XXV CONGRESS-Argentina-2025-Seguridad, eficacia, efectividad e inmunogenicidad de vacunas contra el Chikunguña: una revisión sistemática viva y un metaanálisis.

Salva F., Ballivián J., Bardach A., Brizuela ME., Caravario J., Castellana N., Couto E., Mazzoni A., Ortega V., Sambade JM., Scarafia F., Smutny JP., Stegelmann K, Ciapponi A., Berrueta, M.

Chikungunya

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

Bardach A., Brizuela ME., Berrueta M., Ciapponi A., Sambade JM., Ballivian J., Ortega V., Castellana N., Comandé D., Parker E., Kampmann B., Stegelmann K., Xiong X., Stergachis A., Munoz F., Buekens P., Mazzoni A.

Chikungunya

Safety, immunogenicity, and effectiveness of Chikungunya vaccines in newborns, infants, children, and adolescents: a living systematic review and meta-analysis-Protocol

Berrueta M., Ciapponi A., Mazzoni A., Ballivian J., Bardach A., Sambade JM., Brizuela ME., Stegelmann K., Parker E., Stergachis A., Xiong X., Munoz F., Buekens P.

Chikungunya

Safety, effectiveness, and immunogenicity of Chikungunya vaccines in pregnant persons: a living systematic review and meta-analysis-Protocol

Berrueta M., Ciapponi A., Mazzoni A., Ballivian J., Bardach A., Sambade JM., Brizuela ME., Stegelmann K., Parker E., Stergachis A., Xiong X., Munoz F., Buekens P.

Up-to-date evidence-based information on emerging vaccines in pregnancy and childhood.

Quick Links

Contact Us

Andrea Meyer

ameyer1@tulane.edu